Note 17 - Fair Value Disclosures - Fair Value of Financial Instruments (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Reported Value Measurement [Member]
Cash and cash equivalents	$ 598	$ 3,193
Other receivables	422,034	418,905
Note receivable - related party	44,859	44,859
Advances to CEN Biotech Ukraine, LLC - related party	1,035,328	875,328
Loans payable	10,115,713	10,107,205
Loans payable - related parties	1,361,881	1,360,806
Patent acquisition liability	1,010,000	1,010,000
Convertible notes payable	5,851,725	5,143,647
Convertible notes payable - related parties	2,558,681	2,538,681
Estimate of Fair Value Measurement [Member]
Cash and cash equivalents	598	3,193
Other receivables	422,034	418,905
Note receivable - related party	44,859	44,859
Advances to CEN Biotech Ukraine, LLC - related party	1,035,328	875,328
Loans payable	10,115,713	10,107,205
Loans payable - related parties
Patent acquisition liability	1,010,000	1,010,000
Convertible notes payable	6,461,632	5,534,810
Convertible notes payable - related parties
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents
Other receivables
Note receivable - related party
Advances to CEN Biotech Ukraine, LLC - related party
Loans payable
Loans payable - related parties
Patent acquisition liability
Convertible notes payable
Convertible notes payable - related parties
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents	598	3,193
Other receivables
Note receivable - related party
Advances to CEN Biotech Ukraine, LLC - related party
Loans payable
Loans payable - related parties
Patent acquisition liability
Convertible notes payable
Convertible notes payable - related parties
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents
Other receivables	422,034	418,905
Note receivable - related party	44,859	44,859
Advances to CEN Biotech Ukraine, LLC - related party	1,035,328	875,328
Loans payable	10,115,713	10,107,205
Loans payable - related parties
Patent acquisition liability	1,010,000	1,010,000
Convertible notes payable	6,461,632	5,534,810
Convertible notes payable - related parties